AACC uses Cookies to ensure the best website experience. Continuing without changing Cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy

Fighting CKD Together: The Patient, Clinician, and Laboratorian Perspective

  • Credit:1.5 ACCENT Credits
  • Duration: 1.5 Hours
  • Date:APR.1.2021 12:00 PM
  • Level: Basic

Price: $0.00

Member Price: $0.00

Rating: Member Average

This program was originally presented during the 2020 AACC Annual Scientific Meeting, held virtually from December 13-17, 2020.

Register for this webinar to learn about implementing the laboratory-driven Kidney Profile Choosing Wisely recommendations in integrated healthcare settings. With your registration, you will have access to the recording on demand through April 30, 2022.

When you register for this on demand webinar, you will receive a special promo code for a 25% discount off of your purchase of 2020 AACC Session Recordings.

DESCRIPTION

Chronic Kidney Disease (CKD) is a public health issue. Strategies to identify patients with early CKD are needed to introduce therapy early in the disease course to slow progression, increase patient engagement and extend the quality of life. The National Kidney Foundation Laboratory Engagement Initiative is addressing this situation by collaborating with large laboratories, pathology organizations and healthy systems to promote a harmonized approach to improve the ease of ordering and interpreting the appropriate CKD testing based on clinical practice guidelines. The initiative includes harmonizing confusing laboratory test nomenclature and test results reporting formats, standardizing equations utilized to estimate glomerular filtration rate, and streamlining test ordering procedures by introducing a kidney profile that includes the recommend tests for screening and monitoring adults at risk with diabetics and/or hypertension. Improvements in test ordering and reporting will facilitate the use of clinical laboratory data in the implementation of a CKD population health model in primary care to identify and treat people with CKD earlier in the course of their disease.

Implementing population health initiatives in integrated care settings requires education, collaboration, and creativity to drive success. This session brings together a patient, a clinician, and a laboratorian to discuss the strategies employed to implement the laboratory-driven Kidney Profile Choosing Wisely recommendations in integrated healthcare settings.

TARGET AUDIENCE

This activity is designed for Lab supervisors, Lab directors (and/or assistant directors), Lab managers (supervisory and/or non-supervisory), Medical technologists, Pathologists, Physicians, In-training individuals, and Other laboratory professionals involved with CKD.

LEARNING OBJECTIVES

At the end of this activity, participants will be able to:

  • Define the clinical and cost implications of timely recognition of CKD.
  • Describe the specific actions that each laboratory can take to remove barriers to CKD assessment in primary care.
  • Summarize the components of the successful implementation of a laboratory-driven population health initiative in an integrated care setting.

FACULTY

David G. Grenache, PhD, DABCC, FAACC
Chief Scientific Officer
Tricore Reference Laboratories
Albuquerque, NM

Alexis Conell
Kidney Disease: A Personal Journey
Cleveland, OH

Joseph Vassalotti, MD
Clinical Context for the Kidney Profile: Opportunities for Improvement in 2020
Chief Medical Officer
National Kidney Foundation
New York, NY

Greg Miller, PhD, DABCC, FAACC
Laboratory Tests for the Kidney Profile: Opportunities for Improvement in 2020
Professor of Pathology; Director of Pathology Information Systems; Co-Director of Clinical Chemistry
Virginia Commonwealth University
Richmond, VA

DISCLOSURES AND STATEMENT OF INDEPENDENCE

AACC is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.

The following faculty reported the following relevant financial relationship(s) during the content development process for this activity:

Joseph Vassalotti, MD

  • Consultant fee, Janssen, Inc. and RenalytixAI

The following faculty and reviewers reported no relevant financial relationship:

David G. Grenache, PhD, DABCC, FAACC; Alexis Conell; and Greg Miller, PhD, DABCC, FAACC

CONTENT VALIDITY

All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; AND/OR All scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.

ACCREDITATION STATEMENT

This activity is approved for 1.5 ACCENT® continuing education credits. Activity ID# 2106. This activity was planned in accordance with ACCENT® Standards and Policies.

Release date: April 01, 2021

Credit valid through: April 30, 2022

SUCCESSFUL COMPLETION STATEMENT

Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email [email protected].

In Collaboration With

National Kidney Foundation Logo

Discount on AACC Session Recordings

When you register for this on demand webinar, you will receive a special promo code for a 25% discount off of your purchase of 2020 AACC Session Recordings.